文献速递中枢神经肿瘤放疗放疗物理与技术

胶质母细胞瘤术中放射治疗中剂量学形式体系的评估

Evaluation of Dosimetry Formalisms in Intraoperative Radiation Therapy of Glioblastoma.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-05-05

本研究针对INTRAGO临床试验中8例新诊断胶质母细胞瘤患者,回顾性比较五种剂量学方法计算INTRABEAM术中放疗剂量对危及器官受量的影响。TARGIT方法显示所有病例均满足危及器官剂量约束,而其他方法估算的危及器官平均剂量更高,其中1例脑干约束被超出。更精确的蒙特卡罗组织剂量计算显示脑干、视交叉、视神经和晶状体分别有3、3、2、2例超出剂量约束,且脑干平均累积剂量超过66 Gy约束。

要点

  • TARGIT方法计算术中放疗剂量时所有病例均满足危及器官剂量约束。
  • 其他剂量学方法估算的危及器官平均剂量更高,1例脑干约束被超出。
  • 蒙特卡罗组织剂量法显示脑干、视交叉、视神经、晶状体分别有3、3、2、2例超出约束。

核心结论

  • 当前采用TARGIT方法计算术中放疗剂量可能大幅低估邻近危及器官的受量。
  • 更精确的方法显示危及器官剂量约束可能已被超出。

研究设计与样本

  • 开发INTRABEAM治疗计划框架,回顾性计算8例INTRAGO患者的术中放疗剂量。
  • 患者接受术中放疗处方剂量20至30 Gy,并联合外照射放疗。

主要发现

  • TARGIT方法显示所有病例均满足危及器官剂量约束。
  • 其他形式体系估算的危及器官平均剂量更高,并发现1例脑干约束被超出。
  • 外照射放疗与TARGIT术中放疗剂量相加后,共10例危及器官超出剂量约束。
  • 蒙特卡罗组织剂量法显示脑干、视交叉、视神经和晶状体分别有3、3、2、2例(共8例)超出剂量约束。
  • 蒙特卡罗组织剂量法显示脑干平均累积剂量超过其66 Gy约束,而当前INTRAGO临床实践未显示此情况。

关键数值与推荐

  • 脑干剂量约束为66 Gy。
  • 术中放疗处方剂量为20至30 Gy,并联合外照射放疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The intraoperative radiotherapy in newly diagnosed glioblastoma multiforme (INTRAGO) clinical trial assesses survival in patients with glioblastoma treated with intraoperative radiation therapy (IORT) using the INTRABEAM. Treatment planning for INTRABEAM relies on vendor-provided in-water depth dose curves obtained according to the TARGeted Intraoperative radioTherapy (TARGIT) dosimetry protocol. However, recent studies have shown discrepancies between the estimated TARGIT and delivered doses. This work evaluates the effect of the choice of dosimetry formalism on organs at risk (OAR) doses. METHODS AND MATERIALS: A treatment planning framework for INTRABEAM was developed to retrospectively calculate the IORT dose in 8 INTRAGO patients. These patients received an IORT prescription dose of 20 to 30 Gy in addition to external beam radiation therapy. The IORT dose was obtained using (1) the TARGIT method; (2) the manufacturer's V4.0 method; (3) the CQ method, which uses an ionization chamber Monte Carlo (MC) calculated factor; (4) MC dose-to-water; and (5) MC dose-to-tissue. The IORT dose was converted to 2 Gy fractions equivalent dose. RESULTS: According to the TARGIT method, the OAR dose constraints were respected in all cases. However, the other formalisms estimated a higher mean dose to OARs and revealed 1 case where the constraint for the brain stem was exceeded. The addition of the external beam radiation therapy and TARGIT IORT doses resulted in 10 cases of OARs exceeding the dose constraints. The more accurate MC calculation of dose-to-tissue led to the highest dosimetric differences, with 3, 3, 2, and 2 cases (out of 8) exceeding the dose constraint to the brain stem, optic chiasm, optic nerves, and lenses, respectively. Moreover, the mean cumulative dose to brain stem exceeded its constraint of 66 Gy with the MC dose-to-tissue method, which was not evident with the current INTRAGO clinical practice. CONCLUSIONS: The current clinical approach of calculating the IORT dose with the TARGIT method may considerably underestimate doses to nearby OARs. In practice, OAR dose constraints may have been exceeded, as revealed by more accurate methods.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ayala Alvarez DS, Watson PGF, Popovic M, et al. Evaluation of Dosimetry Formalisms in Intraoperative Radiation Therapy of Glioblastoma. Int J Radiat Oncol Biol Phys. 2023. PMID: 37150259. doi:10.1016/j.ijrobp.2023.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。